Interaction of sirolimus and everolimus with hepatic and intestinal organic anion-transporting polypeptide transporters (Q39552173)

13 September 2017

title

Interaction of sirolimus and everolimus with hepatic and intestinal organic anion-transporting polypeptide transporters (English)

1 reference

13 September 2017

1 reference

6

Pierre Marquet

0 references

author name string

Nicolas Picard

1

1 reference

13 September 2017

Laure Levoir

2

1 reference

13 September 2017

Fabien Lamoureux

3

1 reference

13 September 2017

Sook Wah Yee

4

1 reference

13 September 2017

Kathleen M Giacomini

5

1 reference

13 September 2017

language of work or name

English

0 references

publication date

27 April 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

41

1 reference

13 September 2017

issue

9

1 reference

13 September 2017

page(s)

752-757

1 reference

Safety and efficacy of statin therapy in patients switched from cyclosporine a to sirolimus after cardiac transplantation.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Pharmacogenetics of the organic anion transporting polypeptide 1A2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Impact of OATP transporters on pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Pharmacokinetic and pharmacodynamic assessments of HMG-CoA reductase inhibitors when coadministered with everolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Vascular endothelial growth factor and mTOR pathways in renal cell carcinoma: differences and synergies of two targeted mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Role of OATP transporters in the disposition of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Pharmacokinetic and pharmacodynamic interactions between the immunosuppressant sirolimus and the lipid-lowering drug ezetimibe in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months' follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Use of the new proliferation signal inhibitor everolimus in renal transplant patients in Spain: preliminary results of the EVERODATA registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Predominant contribution of organic anion transporting polypeptide OATP-B (OATP2B1) to apical uptake of estrone-3-sulfate by human intestinal Caco-2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

A fully automated turbulent-flow liquid chromatography-tandem mass spectrometry technique for monitoring antidepressants in human serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.573882

10.3109/00498254.2011.573882

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference